PDS Biotechnology CorporationPDSBNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank62
3Y CAGR-13.3%
5Y CAGR+19.3%
Year-over-Year Change
Research and development spending
3Y CAGR
-13.3%/yr
vs +144.0%/yr prior
5Y CAGR
+19.3%/yr
Recent deceleration
Acceleration
-157.3pp
Decelerating
Percentile
P62
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $19.15M | -15.1% |
| 2024 | $22.57M | -18.7% |
| 2023 | $27.76M | -5.7% |
| 2022 | $29.43M | +161.5% |
| 2021 | $11.25M | +42.0% |
| 2020 | $7.92M | +29.9% |
| 2019 | $6.10M | +634.2% |
| 2018 | $830744.00 | -97.6% |
| 2017 | $34.31M | +38.2% |
| 2016 | $24.82M | - |